Sponsored Article Image

A message from Curtiss-Wright

High-Temperature neutron flux detectors for Generation IV reactors and SMRs

Learn More

Research & Applications

Bruce Power receives regulatory approval to produce medical Lu-177

September 29, 2021, 9:27AMNuclear News
The Bruce nuclear power plant in Ontario, Canada. (Photo: Bruce Power)

Bruce Power has received approval from the Canadian Nuclear Safety Commission (CNSC) to begin the production of lutetium-177, becoming the first power reactor globally to commercially produce the medical radioisotope. Isogen, a joint venture between Framatome and Kinectrics, will produce Lu-177 at Bruce’s eight-unit CANDU nuclear power plant in Ontario, Canada, using Isogen’s isotope production system (IPS).

To continue reading, log in or create a free account!

Related Articles

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

Wheeler River mining project gets go-ahead

February 24, 2026, 10:56AMNuclear News

Canada’s first in situ recovery (ISR) uranium mining operation has been granted final regulatory approval. Toronto-based Denison Mines Corp. announced last week that the Canadian Nuclear...

Saskatchewan expands its nuclear plans

January 30, 2026, 12:21PMNuclear News

This week, the government of Saskatchewan, alongside electric utility SaskPower, announced plans to formally evaluate the deployment of large nuclear technologies. This process will take place...

A trip abroad

November 17, 2025, 7:01AMNuclear NewsHash Hashemian

In my August column in Nuclear News, I reflected on the importance of ANS’s annual conferences for bringing together our nuclear community at the national level. In September, after speaking...